Robaxin® 750mg Tablets recalled over labeling errors
- Recall date
- May 2, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Endo Pharmaceuticals recalls Endo Pharmaceuticals — Robaxin® (methocarbamol tablets, USP) 750mg Tablets
- Brand / firm
- Endo Pharmaceuticals, Endo Pharmaceuticals
Why it was recalled
Incorrect Daily Dosing Information on Label — Mislabeling
What was recalled
Robaxin® (methocarbamol tablets, USP) 750mg Tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Endo Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Endo Pharmaceuticals, Endo Pharmaceuticals